External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Gynaecology Endometriosis

Endometriosis

What's new

Sign up or login to unlock the full suite of MEDICALLY features
Jun 15 / Roche
Multicentre evaluation of blood-based biomarkers for the detection of endometriosis and adenomyosis
The long time between symptom onset and diagnosis in patients with endometriosis and/or adenomyosis results in disease progression and negatively impacts patients’ quality of life. Blood-based biomarker testing may facilitate earlier detection of these diseases relative to current diagnostic techniques. This study evaluated candidate blood-based biomarkers, or biomarker combinations, to aid the detection of suspected endometriosis and/or adenomyosis in women with chronic pelvic pain and/or unexplained subfertility with high sensitivity.
Gynaecology Endometriosis EEC-2022

Ask a question or share feedback

Get in touch

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.